Itron, Inc. (NASDAQ:ITRI) Receives $137.10 Consensus Target Price from Analysts

Itron, Inc. (NASDAQ:ITRI) has received a consensus rating of “Moderate Buy” from the thirteen research firms that are presently covering the company, Marketbeat reports. Five investment analysts have rated the stock with a hold recommendation and eight have issued a buy recommendation on the company. The average 12-month price target among brokers that have updated their coverage on the stock in the last year is $133.10.

A number of research firms have recently commented on ITRI. Zacks Research upgraded shares of Itron from a “strong sell” rating to a “hold” rating in a research report on Thursday, February 26th. Needham & Company LLC started coverage on shares of Itron in a report on Friday, March 6th. They set a “buy” rating and a $124.00 target price on the stock. Guggenheim set a $155.00 target price on shares of Itron in a research note on Friday, February 13th. JPMorgan Chase & Co. cut their price target on shares of Itron from $133.00 to $113.00 and set an “overweight” rating for the company in a report on Thursday. Finally, Oppenheimer boosted their price target on shares of Itron from $133.00 to $135.00 and gave the company an “outperform” rating in a research report on Thursday.

Itron Stock Performance

NASDAQ:ITRI opened at $98.43 on Wednesday. The business’s fifty day moving average is $93.73 and its 200 day moving average is $101.40. The firm has a market cap of $4.36 billion, a price-to-earnings ratio of 15.12, a PEG ratio of 0.86 and a beta of 1.50. The company has a debt-to-equity ratio of 0.45, a quick ratio of 1.56 and a current ratio of 1.80. Itron has a 52-week low of $83.51 and a 52-week high of $142.00.

Itron (NASDAQ:ITRI) last issued its earnings results on Tuesday, February 17th. The scientific and technical instruments company reported $2.46 EPS for the quarter, topping the consensus estimate of $2.19 by $0.27. The business had revenue of $571.66 million during the quarter, compared to the consensus estimate of $561.31 million. Itron had a return on equity of 20.04% and a net margin of 12.72%.The firm’s revenue was down 6.7% compared to the same quarter last year. During the same quarter last year, the company earned $1.35 EPS. Itron has set its Q1 2026 guidance at 1.200-1.300 EPS and its FY 2026 guidance at 5.750-6.250 EPS. Research analysts predict that Itron will post 5.33 EPS for the current year.

Insider Activity at Itron

In other Itron news, CFO Joan S. Hooper sold 3,533 shares of the firm’s stock in a transaction dated Thursday, February 26th. The stock was sold at an average price of $95.92, for a total value of $338,885.36. Following the sale, the chief financial officer owned 118,275 shares of the company’s stock, valued at $11,344,938. This trade represents a 2.90% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, SVP Christopher E. Ware sold 763 shares of Itron stock in a transaction dated Friday, February 20th. The shares were sold at an average price of $100.17, for a total value of $76,429.71. Following the sale, the senior vice president owned 31,043 shares of the company’s stock, valued at approximately $3,109,577.31. This trade represents a 2.40% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold 51,180 shares of company stock valued at $5,085,475 in the last ninety days. 1.77% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Itron

Institutional investors and hedge funds have recently bought and sold shares of the stock. Vanguard Group Inc. lifted its position in Itron by 2.3% during the third quarter. Vanguard Group Inc. now owns 5,875,153 shares of the scientific and technical instruments company’s stock valued at $731,809,000 after purchasing an additional 132,329 shares during the last quarter. Impax Asset Management Group plc increased its holdings in shares of Itron by 127.3% in the 3rd quarter. Impax Asset Management Group plc now owns 1,588,950 shares of the scientific and technical instruments company’s stock worth $197,153,000 after buying an additional 890,040 shares during the last quarter. Dimensional Fund Advisors LP raised its position in shares of Itron by 18.1% during the 4th quarter. Dimensional Fund Advisors LP now owns 1,271,042 shares of the scientific and technical instruments company’s stock valued at $118,034,000 after buying an additional 194,768 shares in the last quarter. Geode Capital Management LLC lifted its holdings in shares of Itron by 0.6% during the 4th quarter. Geode Capital Management LLC now owns 1,144,982 shares of the scientific and technical instruments company’s stock worth $106,340,000 after acquiring an additional 6,598 shares during the last quarter. Finally, Handelsbanken Fonder AB lifted its holdings in shares of Itron by 6.0% during the 3rd quarter. Handelsbanken Fonder AB now owns 999,882 shares of the scientific and technical instruments company’s stock worth $124,545,000 after acquiring an additional 56,318 shares during the last quarter. 96.19% of the stock is owned by hedge funds and other institutional investors.

Itron Company Profile

Itron, Inc (NASDAQ: ITRI) is a global technology company that develops innovative solutions to measure, manage and analyze the use of energy and water. Its comprehensive portfolio includes smart meters, data collection devices, communication networks and advanced software applications designed to optimize utility operations and foster sustainable resource management. The company’s offerings enable utilities and cities to accurately monitor consumption patterns, streamline billing processes and improve grid reliability.

Itron’s product lineup spans a range of hardware and software solutions, from residential and commercial smart meters to meter data management systems (MDMS), networked communication platforms and analytics tools.